{"id":"W4388048382","doi":"10.1136/jitc-2023-sitc2023.0588","title":"588 Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer (pA/rEC) in the RUBY trial: post hoc analysis of the costs of grade ≥3 adverse events (AEs)","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"U.S. National Library of Medicine","keywords":"Placebo; Medicine; Post-hoc analysis; Carboplatin; Internal medicine; Oncology; Urology; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004108281,0.0001897148,0.0004290426,0.0001235209,0.00007096484,0.000007648293,0.0002734899,0.0001082357,0.00000275164],"category_scores_gemma":[0.0003813934,0.0001014589,0.0003537034,0.0006729477,0.0002131212,0.000006093176,0.00004057389,0.00005709221,1.40407e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007958784,"about_ca_system_score_gemma":0.0004102568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004661744,"about_ca_topic_score_gemma":0.001177936,"domain_scores_codex":[0.9986638,0.00008658597,0.0005109368,0.000273612,0.0002465026,0.000218539],"domain_scores_gemma":[0.9985811,0.0003356107,0.0004156807,0.0004833513,0.0001097223,0.00007456036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1114844,0.003885277,0.04214031,0.0007239239,0.009989996,0.00001464346,0.007749182,0.01889961,0.6838167,0.0005330978,0.004367399,0.1163955],"study_design_scores_gemma":[0.08917908,0.009553777,0.3538802,0.0003255232,0.003882556,0.000008556648,0.002784833,0.0007194331,0.483545,0.0002909186,0.05503836,0.0007917103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931146,0.00344681,0.000006694528,0.0007994832,0.0004693843,0.001373777,0.0007740454,0.000003564282,0.00001163634],"genre_scores_gemma":[0.9849837,0.01417393,0.00009617994,0.0001730633,0.0001335801,0.0001863267,0.0001871095,0.00002017166,0.00004590702],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3117399,"threshold_uncertainty_score":0.4137376,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02494451060476337,"score_gpt":0.2918865903691605,"score_spread":0.2669420797643972,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}